However, neither VEGF expression levels nor tumour microvessel density (MVD) were found to be predictive of treatment response, disease progression or death in CRC patients receiving chemotherapy plus the antibody (Jubb et al, 2006a). This evidence concerns the gene VEGFA and neoplasm.